https://www.law360.com/health/articles/1872/knobbe-martens-team-wins-judgment-against-another-tyco-unit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T03:54:10Z monthly 0.5 https://www.law360.com/health/articles/1863/anda-filing-not-willful-patent-infringement-per-se-federal-circuit-rules?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T21:16:13Z monthly 0.5 https://www.law360.com/health/articles/1871/pfizer-loses-marketing-exclusivity-for-diflucan?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T09:24:16Z monthly 0.5 https://www.law360.com/health/articles/1852/judge-grants-summary-judgment-for-gen-probe-in-enzo-s-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T14:29:40Z monthly 0.5 https://www.law360.com/health/articles/1853/chinese-drug-makers-target-glaxo-drug-citing-viagra-decision?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:25:07Z monthly 0.5 https://www.law360.com/health/articles/1854/appeals-court-orders-fda-to-stay-anda-approval-for-neurontin-generic-capsules?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T19:20:25Z monthly 0.5 https://www.law360.com/health/articles/1843/long-term-biotech-client-sues-townsend-for-malpractice?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T06:44:50Z monthly 0.5 https://www.law360.com/health/articles/1837/orasure-sues-schering-plough-for-cryosurgical-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T16:57:08Z monthly 0.5 https://www.law360.com/health/articles/1840/aventis-loses-second-lovenox-patent-reissuance-bid?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:12:57Z monthly 0.5 https://www.law360.com/health/articles/1829/thermage-sues-syneron-over-patent-for-wrinkle-treatment?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:15:01Z monthly 0.5 https://www.law360.com/health/articles/1841/indian-generic-makers-offer-4-of-turnover-in-royalty-under-new-patent-regime?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T18:32:49Z monthly 0.5 https://www.law360.com/health/articles/1826/mylan-acquires-king-for-4b-in-move-toward-branded-drugs?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:55:35Z monthly 0.5 https://www.law360.com/health/articles/1827/cipla-eyes-generic-challenge-to-sanofi-synthelabo-s-plavix?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T20:23:21Z monthly 0.5 https://www.law360.com/health/articles/1810/astrazeneca-sues-andrx-over-toprol-xl-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T03:35:10Z monthly 0.5 https://www.law360.com/health/articles/1806/plavix-patent-trial-delayed?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:29:11Z monthly 0.5 https://www.law360.com/health/articles/1791/european-patent-office-revokes-merck-s-fosamax-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T09:08:33Z monthly 0.5 https://www.law360.com/health/articles/1790/teva-files-paragraph-iv-anda-for-avapro?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T09:56:57Z monthly 0.5 https://www.law360.com/health/articles/1783/abbott-settles-suits-over-norvir-amid-calls-for-compulsory-license?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T19:20:25Z monthly 0.5 https://www.law360.com/health/articles/1780/pfizer-trade-group-protest-china-s-overturn-of-viagra-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T05:13:25Z monthly 0.5 https://www.law360.com/health/articles/1784/inverness-medical-innovations-granted-injunction-against-acon-laboratories-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T17:47:45Z monthly 0.5 https://www.law360.com/health/articles/1774/dr-reddy-s-files-fda-drugmaster-application-for-nexium?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:55:34Z monthly 0.5 https://www.law360.com/health/articles/1771/nellcor-says-court-rules-in-its-favor-in-masimo-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:41:34Z monthly 0.5 https://www.law360.com/health/articles/1768/federal-circuit-rules-for-bristol-myers-in-repligen-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T04:43:48Z monthly 0.5 https://www.law360.com/health/articles/1761/philips-sues-gillette-over-electric-toothbrush-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T06:48:55Z monthly 0.5 https://www.law360.com/health/articles/1755/india-eyes-patent-reforms-without-industry-input?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-10T23:32:13Z monthly 0.5 https://www.law360.com/health/articles/1751/federal-circuit-abbott-did-not-infringe-novartis-patent-for-human-transplant-drug?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T04:26:03Z monthly 0.5 https://www.law360.com/health/articles/1756/u-s-israel-deadlocked-over-data-exclusivity-rules?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T12:48:56Z monthly 0.5 https://www.law360.com/health/articles/1747/glaxosmithkline-to-pay-92m-to-settle-suits-over-patent-gaming?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T21:11:59Z monthly 0.5 https://www.law360.com/health/articles/1746/new-zealand-reaffirms-ban-on-methods-patents?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T02:00:27Z monthly 0.5 https://www.law360.com/health/articles/1738/xcel-sues-par-pharma-unit-over-anda-for-diastat-generic?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:59:57Z monthly 0.5 https://www.law360.com/health/articles/1730/china-overturns-pfizer-s-viagra-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T02:36:47Z monthly 0.5 https://www.law360.com/health/articles/1734/partial-victory-for-pfizer-in-xalatan-suit-vs-par?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:55:33Z monthly 0.5 https://www.law360.com/health/articles/1725/european-patent-office-oks-mouse-patent-with-restrictions?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T11:17:52Z monthly 0.5 https://www.law360.com/health/articles/1722/duke-suit-vs-elan-targets-competing-patent-filings?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T16:57:07Z monthly 0.5 https://www.law360.com/health/articles/1727/federal-appeals-court-rejects-hearing-on-cox-2-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:55:32Z monthly 0.5 https://www.law360.com/health/articles/1721/mylan-pays-9m-to-settle-paclitaxel-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T00:26:29Z monthly 0.5 https://www.law360.com/health/articles/1714/house-of-lords-to-hear-amgen-tkt-patent-dispute-next-week?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-10T22:47:06Z monthly 0.5 https://www.law360.com/health/articles/1715/ciba-s-witness-concerns-unfounded-coopervision?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T16:57:06Z monthly 0.5 https://www.law360.com/health/articles/1710/barr-cleared-of-infringing-three-patents-in-allegra-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T08:23:11Z monthly 0.5 https://www.law360.com/health/articles/1701/court-rules-for-pfizer-in-accupril-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T12:31:52Z monthly 0.5 https://www.law360.com/health/articles/1700/federal-judge-dismisses-promega-suit-vs-hoffman-laroche-applera?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T18:54:30Z monthly 0.5 https://www.law360.com/health/articles/1709/mylan-demands-fda-response-to-petition-on-branded-generics-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T22:26:00Z monthly 0.5